Blood Pressure Control May Prevent Over 100,000 Deaths
According to findings from a new study presented at ASN Kidney Week November 15-20 November 2016 at McCormick Place in Chicago, IL, intensive blood pressure lowering may prevent more than 100,000 deaths in the U.S. each year.
The Systolic Blood Pressure Intervention Trial (SPRINT) trial, the largest study of its kind, was conducted with more than 9300 participants aged 50 and older with high blood pressure. Patients were assigned to a systolic blood pressure target of 120 mm Hg or the 140mm Hg and were prescribed medication accordingly. Findings showed that intensive systolic blood pressure lowering to 120 mm Hg prolonged life compared with the standard SBP lowering to 140mm Hg.
See Also: SPRINT Study: Lowering Blood Pressure Lowers CVD Events
Tisha Joerla Tan, MD (Loyola University Medical Center) and her colleagues applied the study's findings to similar individuals in the general US population. Approximately 18.1 million US adults met SPRINT criteria. Intensive blood pressure lowering was projected to prevent nearly 105,000 deaths per year.
"Our analyses also showed that more than 4 million adults with stage 3-4 chronic kidney disease meet SPRINT criteria, and intensive systolic blood pressure lowering was projected to prevent 32,800 deaths per year in this group," said Dr. Tan.
Source: American Society of Nephrology
Image Credit: Pixabay
Published on : Sun, 20 Nov 2016
CNAP® OEM partner solutions
The CNAP® technology is easily integrated into your product using our CNAP® OEM Partner Solutions.
INTEGRATION MADE EASY Discover our CNAP ® OEM partner solutions FULL SET OF NON-INVASIVE CONTINUOUS PATIENT SIGNALS Based on an easy-to-use dual finger sensor, the patented...
Hemodynamic measurement just got easier Task Force ® Touch CARDIO* provides a set of synchronized patient signals derived from the unique non-invasive CNAP ® finger sensor , combined with wireless 12-channel ECG. It is...
The Task Force® Monitor is the all‐in‐one workstation for continuous noninvasive hemodynamic and autonomic assessment. It is the state‐of‐the‐art diagnostic tool to study syncope and autoregulation of blood pressure and has further established as an...
Continuous non-invasive blood pressure, cardiac output and fluid management for moderate and low-risk surgery CNAP ® Monitor provides advanced hemodynamic information from the non-invasive resusable CNAP ® finger sensor . It supports your Goal...